scispace - formally typeset
Q

Qi Wang

Researcher at Guangzhou University of Chinese Medicine

Publications -  295
Citations -  5203

Qi Wang is an academic researcher from Guangzhou University of Chinese Medicine. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 27, co-authored 253 publications receiving 2983 citations. Previous affiliations of Qi Wang include Guangzhou University.

Papers
More filters
Journal ArticleDOI

CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-κB/SOX4 signaling.

Neng Wang, +11 more
- 29 Aug 2018 - 
TL;DR: Bioinformatic analysis and clinical investigation suggested that high CXCL1 expression is significantly correlated with breast cancer lymph node metastasis, poor overall survival and basal-like subtype, and CxCL1-based therapy might become a novel strategy for breast cancer metastasis prevention.
Journal ArticleDOI

In silico polypharmacology of natural products.

Jiansong Fang, +4 more
- 27 Apr 2017 - 
TL;DR: The promise of cancer immunotherapies and combination therapies that target tumor ecosystems (e.g. clones or 'selfish' sub-clones) via exploiting the immunological and inflammatory 'side' effects of natural products in the cancer post-genomics era is highlighted.
Journal ArticleDOI

Deep Learning-Based Prediction of Drug-Induced Cardiotoxicity.

Chuipu Cai, +9 more
- 04 Feb 2019 - 
TL;DR: A powerful deep learning-based tool for risk assessment of hERG-mediated cardiotoxicities in drug discovery and postmarketing surveillance is presented and several novel predicted hERG blockers on approved antineoplastic agents are showcased.
Journal ArticleDOI

Metformin attenuates hyperalgesia and allodynia in rats with painful diabetic neuropathy induced by streptozotocin.

Junxiong Ma, +5 more
- 05 Oct 2015 - 
TL;DR: Investigation in diabetic rats found that metformin is able to attenuate diabetes-induced hyperalgesia and allodynia, which might be associated its anti-oxidative effect through AMPK pathway, and might be used as an effective drug for abnormal sensation in painful diabetic neuropathy.
Journal ArticleDOI

(-)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer's disease model mice by upregulating neprilysin expression.

Xiang Chang, +16 more
- 15 May 2015 - 
TL;DR: It is demonstrated that EGCG reduced β-amyloid accumulation in vitro and rescued cognitive deterioration in senescence-accelerated mice P8 (SAMP8) via intragastric administration of low- and high-dose E GCG (5 and 15 mg/kg, respectively) for 60 days.